LEMTRADA: payments to doctors
Payments that named LEMTRADA as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $4.4M
- Providers
- 2,611
- Transactions
- 13,677
- Average per transaction
- $322
The per-transaction average — $322 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 2,611 providers the average total is $1,689, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Sanofi | $3,882,959 | 88.0% |
| Sanofi-aventis U.S. LLC | $409,708 | 9.3% |
| Sanofi US Services Inc. | $117,489 | 2.7% |